Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Aspects covered in the questionnaire on monitoring of patients using lithium

From: Monitoring of patients treated with lithium for bipolar disorder: an international survey

Aspect Item number Items of question
Lithium serum level monitoring 1–8 Target values for: acute manic episode in adults (18–60 years old), maintenance treatment in adults, acute manic episode in elderly patients (> 60 years old), maintenance treatment in elderly
Frequency of monitoring lithium serum levels during the first month, months 2–6 and per year
Monitoring of physical and laboratory parameters 9–25 Assessment of the following monitoring parameters before, during the first 6 months and during maintenance treatment
Physical parameters: bodyweight, body mass index (BMI), blood pressure, pulse, waist circumference, electrocardiogram (ECG), pregnancy test, 24 h urine examination
Laboratory parameters: creatinine, urea, albumin, glomerular filtration rate (GFR), thyroid stimulating hormone (TSH), parathyroid hormone (PTH), thyroxine (T4), alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), bilirubin, sodium, potassium, calcium, full blood count, leukocytes, leukocyte differentiation, total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (vLDL), triglycerides, fasting glucose
Local system for ensuring monitoring 26–35 Reasons to and not to monitor, assessment usage of guidelines or institutional protocols, responsible health care professional for monitoring, usage of laboratory protocols, method of inviting patients for monitoring
Background information 36–41 Gender, age, profession, institution of employment, years of lithium prescribing, country